Agent Support and Method for Treating a Surface

Publication: EP2937103A1
Published: 2015-10-28
Family Size: 2
Granted: No

Simple SummaryContent extracted from patent full text and abstract with AI.

This patent describes a special dressing or surface treatment pad containing a medium that can be activated by plasma (such as cold atmospheric plasma). When this medium is exposed to plasma, it releases an active agent—typically with antimicrobial or disinfecting properties—that can then be applied to a surface or wound. The invention makes it possible to indirectly treat surfaces using plasma's beneficial effects without applying plasma directly to the target surface.

Use CasesContent extracted from patent full text and abstract with AI.

  • Wound care and wound dressings for infection control and improved healing
  • Disinfection of medical instruments or devices without direct plasma exposure
  • Sterilization and cleaning of sensitive surfaces where direct plasma or harsh chemicals might cause damage
  • Treatment of chronic wounds or burns to enhance antimicrobial activity and healing
  • Antibacterial surface treatments for consumer or industrial applications

BenefitsContent extracted from patent full text and abstract with AI.

  • Enables plasma-activated treatments without exposing patients or surfaces directly to plasma or high voltage, improving safety
  • Allows for controlled and prolonged release of active agents over large or sensitive surface areas
  • Reduces risk of electrical hazards and radiation to patients and healthcare workers
  • Improves flexibility in treating large or irregularly shaped surfaces compared to direct plasma application
  • Potentially enhances wound healing and infection control due to longer-lasting antimicrobial effects from the activated medium

Technical Classifications (CPCs)

Main Classifications

Health, Food & Consumer Tech

Sub Classifications

Medical & Vet Science

CPC Codes

A61L2/14

Inventors & Applicants

Applicants

Inp Greifswald E V

Patent Abstract

Wirkauflage (2) mit einem Wirkmedium (4), dadurch gekennzeichnet, dass das Wirkmedium (4) zur Aktivierung durch Plasma und zur Freisetzung eines Wirkstoffs nach der Plasmaaktivierung ausgebildet ist.

Key Information

Publication No.

EP2937103A1

Family ID

52997956

Publication Date

2015-10-28

Application No.

EP15164725A

Application Date

2015-04-22

Priority Date

2014-04-23

Granted

No

Possible Cooperation

For further information please contact the transfer office.